Aesculap, Inc. Launches MINOP® InVent: The Future of Neuroendoscopy
MINOP InVent - Offering more for patients through less invasive techniques
- Eliminates the need for additional brain retraction
- Allows for Bimanual resection of large tumors and cysts
- Enhanced ability to perform hemostasis and coagulation
- Specialized instrumentation with up to 32 options available
- Unparalleled HD Optical System featuring a larger image
“As a leader within the neurosurgical community, Aesculap is committed to providing innovative technology for our customers and their patients. InVent embodies this philosophy in offering a new solution for Advanced Neurosurgeons and expanding the possibilities for Minimally Invasive Neurosurgery,” said Aesculap, Inc. President, Chuck DiNardo.
MINOP Indications
The MINOP System is intended for use in endoscope-assisted microneurosurgery and pure neuroendoscopy (i.e. ventriculoscopy) for direct visualization, diagnostic and/or therapeutic procedures, such as ventriculostomies, biopsies and removal of cysts, tumors and other obstructions.
To learn more about the MINOP product line including InVent, visit www.aesculapusa.com or contact your local Aesculap Sales Representative.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun company, founded in 1867 in Tuttlingen, Germany, is the world’s largest and one of the most respected manufacturers of surgical instruments and sterilization container systems. Aesculap is a leading privately-owned manufacturing company, passionately committed to providing high-quality, innovative products and services to all surgical disciplines, with particular focus in the fields of General, Neuro, Spine and Orthopaedics. For more information, contact Aesculap Customer Service at 1-800-282-9000 or visit www.aesculapusa.com.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun group of companies includes B.Braun, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania, with its global headquarters based in Melsungen, Germany. It employs more than 44,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.bbraunusa.com.
Contact:
Amy Burkey
Project Manager, Corporate Communications Aesculap, Inc.610-984-9245
Tags:
